OFI Invest Asset Management purchased a new position in Palantir Technologies Inc. (NASDAQ:PLTR – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 424,690 shares of the company’s stock, valued at approximately $75,489,000. Palantir Technologies makes up approximately 1.0% of OFI Invest Asset Management’s investment portfolio, making the stock its 21st largest position.
Several other hedge funds and other institutional investors also recently modified their holdings of PLTR. Bare Financial Services Inc grew its holdings in shares of Palantir Technologies by 54.5% during the third quarter. Bare Financial Services Inc now owns 156 shares of the company’s stock worth $28,000 after purchasing an additional 55 shares in the last quarter. Delos Wealth Advisors LLC purchased a new position in shares of Palantir Technologies during the second quarter worth about $29,000. Zeit Capital LLC purchased a new position in shares of Palantir Technologies during the second quarter worth about $30,000. Financial Consulate Inc. purchased a new position in shares of Palantir Technologies during the third quarter worth about $30,000. Finally, Retirement Wealth Solutions LLC purchased a new position in shares of Palantir Technologies during the third quarter worth about $31,000. Hedge funds and other institutional investors own 45.65% of the company’s stock.
Palantir Technologies Price Performance
NASDAQ:PLTR opened at $140.76 on Thursday. The business has a 50 day moving average of $144.76 and a 200 day moving average of $167.09. The company has a market capitalization of $336.65 billion, a price-to-earnings ratio of 223.43, a PEG ratio of 2.94 and a beta of 1.68. Palantir Technologies Inc. has a 1-year low of $77.27 and a 1-year high of $207.52.
Insider Buying and Selling
In related news, insider David A. Glazer sold 17,438 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $133.72, for a total value of $2,331,809.36. Following the completion of the sale, the insider owned 392,370 shares in the company, valued at $52,467,716.40. The trade was a 4.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Stephen Andrew Cohen sold 327,088 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $133.72, for a total value of $43,738,207.36. Following the completion of the sale, the insider owned 592 shares of the company’s stock, valued at $79,162.24. The trade was a 99.82% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,029,879 shares of company stock worth $137,746,253 over the last ninety days. Corporate insiders own 9.23% of the company’s stock.
Palantir Technologies News Roundup
Here are the key news stories impacting Palantir Technologies this week:
- Positive Sentiment: Large commercial deal expansion — Stellantis renewed and expanded its partnership to deploy Palantir’s data and AI across auto operations, a meaningful commercial win that supports recurring revenue and enterprise adoption. Stellantis Balances US Model Refreshes With Expanded Palantir AI Push
- Positive Sentiment: Bullish price targets and analyst optimism — multiple pieces highlight upside scenarios (including $225–$230 targets) and upgrades that reflect expectations for Palantir to convert AI demand into sustained revenue growth. These can underpin momentum if results keep beating estimates. Prediction: This Will Be Palantir’s Stock Price in 1 Year
- Positive Sentiment: Product/market traction — conference coverage (DevCon5) and recent commentary note rising customer counts, larger contract values and strong revenue growth — fundamental drivers that support longer‑term upside. Palantir: DevCon5 Shows A Disruptor, Not The Disrupted
- Neutral Sentiment: UK/NHS developments are mixed — an NHS data chief publicly praises Palantir’s results and pushes for wider rollout, which could mean larger public contracts, but the story remains politically and ethically charged. Policymaker and staff pushback creates execution and PR risk. NHS data chief pushes for deeper rollout of Palantir technology despite outcry
- Negative Sentiment: High‑profile criticism from Michael Burry — public warnings that Palantir is overvalued and that competitors like Anthropic are taking enterprise AI share triggered a sharp investor reaction and a ~6% intraday decline in coverage reports. That criticism amplifies valuation scrutiny for a richly priced stock. Palantir (PLTR) Stock Tumbles 6% Following Burry’s Anthropic Competition Warning
- Negative Sentiment: Regulatory and ethical scrutiny — continued UK pressure, calls for boycotts, and broader questions about government/healthcare contracts increase political and contractual risk that could slow public sector deal growth or add costs. Palantir Faces Burry Critique And UK Scrutiny As Anthropic Competition Grows
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on PLTR. Jefferies Financial Group set a $208.00 price objective on Palantir Technologies in a report on Thursday, January 22nd. Citigroup boosted their price objective on Palantir Technologies from $235.00 to $260.00 and gave the stock a “buy” rating in a report on Tuesday, February 3rd. Mizuho raised Palantir Technologies from a “neutral” rating to an “outperform” rating and set a $195.00 price objective for the company in a report on Wednesday, February 18th. Piper Sandler reissued an “overweight” rating and set a $230.00 price objective on shares of Palantir Technologies in a report on Tuesday, February 3rd. Finally, William Blair raised Palantir Technologies from a “market perform” rating to an “outperform” rating in a report on Monday, February 2nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $197.77.
Read Our Latest Stock Analysis on Palantir Technologies
Palantir Technologies Company Profile
Palantir Technologies is a software company that develops data integration, analytics and operational decision-making platforms for government and commercial customers. Founded in 2003 by a team that included Alex Karp and Peter Thiel, Palantir has grown into a provider of enterprise-scale software designed to help organizations integrate disparate data sources, build analytic models and drive operational workflows. The company went public in 2020 and continues to position its products around large, complex data projects where security, provenance and real-time collaboration are important.
Palantir’s product portfolio centers on a small number of core platforms.
See Also
Want to see what other hedge funds are holding PLTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Palantir Technologies Inc. (NASDAQ:PLTR – Free Report).
Receive News & Ratings for Palantir Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palantir Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
